Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC026682 Activators

Glucokinase Activators are a set of chemical compounds that directly or indirectly catalyze the activation of Glucokinase, a key enzyme regulating glucose metabolism in the liver and pancreatic β-cells. Glucose, the natural substrate of Glucokinase, directly enhances its activity through allosteric activation, increasing the enzyme's affinity for glucose and facilitating the phosphorylation of glucose to glucose-6-phosphate, a critical step for glycolysis and glycogen synthesis. Glucosamine and Mannose, as alternative hexose substrates, can also enhance Glucokinase activity by similar allosteric mechanisms. Fructose and Sorbitol act indirectly; the metabolism of these sugars alters the levels of ATP and ADP within the cell, with ADP acting as an allosteric activator of Glucokinase.

BC026682 activators comprise a chemical class that can enhance the activity of the molecular target denoted as BC026682. The discovery process for these activators typically begins with a high-throughput screening (HTS) strategy, where vast compound libraries are methodically tested for their effect on BC026682 activity. The assays used in HTS are designed to provide a quantitative measure of BC026682 activation, often through the employment of colorimetric, fluorescent, or luminescent reporters that directly correlate with the activity of the target. Compounds that demonstrate an ability to upregulate BC026682 activity are flagged for further validation. The subsequent validation phase involves secondary assays, which are more refined and specific than the initial screening. These assays are intended to confirm the activity of the compounds and to rule out non-specific effects or experimental artifacts. They are critically important for verifying that the identified compounds are true activators of BC026682.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates protein kinase C (PKC), which may phosphorylate and activate "BC026682" if it is a substrate of PKC or is involved in PKC-regulated pathways.

Ionomycin, free acid

56092-81-0sc-263405
sc-263405A
1 mg
5 mg
$94.00
$259.00
2
(2)

Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels and potentially activating calcium-dependent kinases that could phosphorylate and activate "BC026682."

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, potentially resulting in downstream signaling events that lead to the activation of "BC026682" through G-protein coupled receptor pathways.

8-Bromoadenosine 3′,5′-cyclic monophosphate

23583-48-4sc-217493B
sc-217493
sc-217493A
sc-217493C
sc-217493D
25 mg
50 mg
100 mg
250 mg
500 mg
$106.00
$166.00
$289.00
$550.00
$819.00
2
(1)

As a cAMP analog, 8-Bromo-cAMP activates PKA, potentially leading to the phosphorylation and activation of "BC026682" if it is a PKA substrate.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$285.00
$520.00
$1300.00
78
(4)

Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins, which could include "BC026682," thereby enhancing its activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 acts as a calcium ionophore and could increase intracellular calcium, potentially activating calcium-dependent signaling pathways that could enhance the function of "BC026682."

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 inhibits PI3K, leading to altered downstream signaling. This could result in compensatory mechanisms or pathway crosstalk that indirectly enhances "BC026682" activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 inhibits MEK1/2 leading to decreased ERK phosphorylation. This could shift signaling dynamics to pathways where "BC026682" is involved, potentially enhancing its activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 specifically inhibits p38 MAPK. The inhibition of this pathway may lead to the activation of alternative pathways, potentially enhancing the activity of "BC026682."

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is a tyrosine kinase inhibitor that could potentiate the activity of "BC026682" by inhibiting competing tyrosine kinase signaling pathways.